Literature DB >> 15998895

Circulating androgen levels and self-reported sexual function in women.

Susan R Davis1, Sonia L Davison, Susan Donath, Robin J Bell.   

Abstract

CONTEXT: It has been proposed that low sexual desire and sexual dysfunction are associated with low blood testosterone levels in women. However, evidence to support this is lacking.
OBJECTIVE: To determine whether women with low self-reported sexual desire and sexual satisfaction are more likely to have low serum androgen levels than women without self-reported low sexual desire and sexual satisfaction. DESIGN, SETTING, AND PARTICIPANTS: A community-based, cross-sectional study of 1423 women aged 18 to 75 years, who were randomly recruited via the electoral roll in Victoria, Australia, from April 2002 to August 2003. Women were excluded from the analysis if they took psychiatric medication, had abnormal thyroid function, documented polycystic ovarian syndrome, or were younger than 45 years and using oral contraception. MAIN OUTCOME MEASURES: Domain scores of the Profile of Female Sexual Function (PFSF) and serum levels of total and free testosterone, androstenedione, and dehydroepiandrosterone sulfate.
RESULTS: A total of 1021 individuals were included in the final analysis. No clinically significant relationships between having a low score for any PFSF domain and having a low serum total or free testosterone or androstenedione level was demonstrated. A low domain score for sexual responsiveness for women aged 45 years or older was associated with higher odds of having a serum dehydroepiandrosterone sulfate level below the 10th percentile for this age group (odds ratio [OR], 3.90; 95% confidence interval [CI], 1.54-9.81; P = .004). For women aged 18 to 44 years, having a low domain score for sexual desire (OR, 3.86; 95% CI, 1.27-11.67; P = .02), sexual arousal (OR, 6.39; 95% CI, 2.30-17.73; P<.001), and sexual responsiveness (OR, 6.59; 95% CI, 2.37-18.34; P<.001) was associated with having a dehydroepiandrosterone sulfate level below the 10th percentile.
CONCLUSIONS: No single androgen level is predictive of low female sexual function, and the majority of women with low dehydroepiandrosterone sulfate levels did not have low sexual function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998895     DOI: 10.1001/jama.294.1.91

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

Review 1.  Menopause and Sexuality.

Authors:  Kimberley Thornton; Judi Chervenak; Genevieve Neal-Perry
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

Review 2.  Pharmacological therapy for female sexual dysfunction: has progress been made?

Authors:  Susan R Davis; Esme A Nijland
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 4.  The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept.

Authors:  Jenny A Higgins; Nicole K Smith
Journal:  J Sex Res       Date:  2016-03-08

5.  Effect of radiotherapy for rectal cancer on ovarian androgen production.

Authors:  J Segelman; C Buchli; A Svanström Röjvall; P Matthiessen; S Arver; M Bottai; M Ahlberg; R Jasuja; A Flöter-Rådestad; A Martling
Journal:  Br J Surg       Date:  2018-09-12       Impact factor: 6.939

6.  Factors Affecting Sexual Function in Midlife Women: Results from the Midlife Women's Health Study.

Authors:  Rebecca L Smith; Lisa Gallicchio; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2017-02-28       Impact factor: 2.681

7.  Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones.

Authors:  Chrisalbeth J Guillermo; Heidi A Manlove; Peter B Gray; David T Zava; Chandler R Marrs
Journal:  BMC Womens Health       Date:  2010-05-27       Impact factor: 2.809

8.  Management of hypoactive sexual desire disorder in women: current and emerging therapies.

Authors:  Rossella E Nappi; Ellis Martini; Erica Terreno; Francesca Albani; Valentina Santamaria; Silvia Tonani; Luca Chiovato; Franco Polatti
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: An exploration in male-to-female transsexuals.

Authors:  E Elaut; V Bogaert; G De Cuypere; S Weyers; L Gijs; J-M Kaufman; G T'Sjoen
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

10.  Factors Affecting Sexual Activity in Midlife Women: Results from the Midlife Health Study.

Authors:  Rebecca L Smith; Lisa Gallicchio; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2016-09-21       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.